PROMOTING ACCESS TO AFRICAN RESEARCH

Tropical Journal of Pharmaceutical Research

Log in or Register to get access to full text downloads.

Remember me or Register



Chemopreventive properties of curcumin analogues, hexagamavunone-0 and gamavutone-0, in rat colorectal cancer model

Risfah Yulianty, Lukman Hakim, Sardjiman Sardjiman, Gemini Alam, Sitarina Widyarini

Abstract


Purpose: To examine the chemopreventive activity of curcumin analogues, hexagamavunone-0 (HGV- 0) and gamavutone-0 (GVT-0), compared to curcumin in a colorectal cancer model in Wistar rats.

Methods: Rats (n = 25) were assigned to one of five groups (n = 5 in each group). Colorectal cancer was induced in the control group with subcutaneous injection of 1,2-dimethylhydrazine (DMH) 60 mg/kg once a week for 15 weeks. In addition to DMH injection, treatment groups were treated with curcumin (20, 40, or 80 mg/kg), gamavutone-0 (GVT-0; 20, 40, or 80 mg/kg), and hexagamavunone (HGV-0; 20, 40, or 80 mg/kg) orally twice a week for 15 weeks. The number and volume of nodules in the colorectal area were observed after laparatomy. Histopathological analysis was performed using H & E staining and immunohistochemistry with antibodies against adenomatous polyposis coli (APC) and cyclooxygenase 2 (COX-2).

Results: All treatments reduced colorectal nodule volume, but only HGV-0 significantly decreased the numbers of nodules compared to DMH controls (p < 0.05). The reduction was 96.1 % with 40 mg/kg HGV-0. Mutated APC expression was inhibited by curcumin, GVT-0, and HGV-0 at a dose of 40 mg/kg, whereas COX-2 expression was mostly inhibited by HGV-0 (20 and 40 mg/kg) and curcumin to a lesser extent, but not inhibited by GVT-0 treatment in rat colorectal cancer.

Conclusion: HGV-0 showed superior chemoprevention compared to GVT-0 and curcumin. HGV-0 at a dose of 40 mg/kg significantly reduced the number and volume of colorectal nodules. The mechanism of chemoprevention of HGV-0 is related to its inhibition of APC mutation and COX-2 expression.

Keywords: Curcumin, Gamavutone-0, Hexagamavunone-0, Colorectal cancer, Adenomatous polyposis coli, Cyclooxygenase-2




http://dx.doi.org/10.4314/tjpr.v16i9.14
AJOL African Journals Online